RAFE Among Large Cap ETFs
End-of-day Nov 18, 2026 · 259 Large cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −4.1% | −1.9% | −0.6% | +19.3% | +24.2% | +76.0% | +67.2% | — | +125.6% |
| Peer average | −0.2% | −3.6% | −4.2% | −4.5% | +7.8% | +11.1% | +60.9% | +50.8% | +219.8% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$57 of every $1,000 in RAFE is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple 00001 | Technology | 5.71% | $571.48 | 28K | $10.0M |
| 2 | MSFTMicrosoft 00000625 | Technology | 5.14% | $513.75 | 18K | $9.0M |
| 3 | JNJJohnson + Johnson Usd1.0 | Healthcare | 3.14% | $313.70 | 20K | $5.5M |
| 4 | UNHUnitedhealth Group 01 | Healthcare | 2.74% | $273.80 | 12K | $4.8M |
| 5 | JPMJpmorgan Chase + Usd1.0 | Financial Services | 2.38% | $237.74 | 13K | $4.2M |
| 6 | PGProcter + Gamble /the | Consumer Defensive | 2.12% | $212.12 | 22K | $3.7M |
| 7 | MRKMerck + 5 | Healthcare | 2.10% | $210.11 | 26K | $3.7M |
| 8 | VZVerizon Communications 1 | Communication Services | 1.92% | $192.20 | 73K | $3.4M |
| 9 | ABBVAbbvie 01 | Healthcare | 1.82% | $182.49 | 11K | $3.2M |
| 10 | TAT+T USD1.0 | Communication Services | 1.68% | $168.18 | 132K | $2.9M |
| 11 | CCitigroup 01 | Financial Services | 1.42% | $142.04 | 21K | $2.5M |
| 12 | PFEPfizer 05 | Healthcare | 1.34% | $134.02 | 82K | $2.3M |
| 13 | MRNAModerna 0001 | Healthcare | 1.22% | $122.32 | 10K | $2.1M |
| 14 | QCOMQualcomm 0001 | Technology | 1.13% | $112.81 | 12K | $2.0M |
| 15 | BMYBristol Myers Squibb 1 | Healthcare | 1.13% | $112.64 | 32K | $2.0M |
of the $834B in 305 Large cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple 00001 | 5.71% |
| 2 | MSFT | Microsoft 00000625 | 5.14% |
| 3 | JNJ | Johnson + Johnson Usd1.0 | 3.14% |
| 4 | UNH | Unitedhealth Group 01 | 2.74% |
| 5 | JPM | Jpmorgan Chase + Usd1.0 | 2.38% |
| 6 | PG | Procter + Gamble /the | 2.12% |
| 7 | MRK | Merck + 5 | 2.10% |
| 8 | VZ | Verizon Communications 1 | 1.92% |
| 9 | ABBV | Abbvie 01 | 1.82% |
| 10 | T | AT+T USD1.0 | 1.68% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Oct 1, 2026 | Oct 5, 2026 | $0.19 |
| Jul 1, 2026 | Jul 6, 2026 | $0.19 |
| Apr 1, 2026 | Apr 3, 2026 | $0.19 |
| Dec 31, 2025 | Jan 5, 2026 | $0.17 |
| Oct 1, 2025 | Oct 3, 2025 | $0.17 |
| Jul 1, 2025 | Jul 3, 2025 | $0.18 |
| Apr 1, 2025 | Apr 3, 2025 | $0.18 |
| Dec 31, 2024 | Jan 3, 2025 | $0.17 |
| Oct 1, 2024 | Oct 3, 2024 | $0.15 |
| Jul 1, 2024 | Jul 3, 2024 | $0.16 |
| Apr 1, 2024 | Apr 4, 2024 | $0.17 |
| Dec 28, 2023 | Jan 3, 2024 | $0.16 |